203 related articles for article (PubMed ID: 9570261)
1. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
[TBL] [Abstract][Full Text] [Related]
2. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice.
Goves J; Oldring JK; Kerr D; Dallara RG; Roffe EJ; Powell JA; Taylor MD
Aliment Pharmacol Ther; 1998 Feb; 12(2):147-57. PubMed ID: 9692689
[TBL] [Abstract][Full Text] [Related]
3. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
6. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
Jones R; Crouch SL
Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
[TBL] [Abstract][Full Text] [Related]
7. Nonprescription doses of ranitidine are effective in the relief of episodic heartburn.
Ciociola AA; Pappa KA; Sirgo MA
Am J Ther; 2001; 8(6):399-408. PubMed ID: 11704778
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.
Jones RH; Baxter G
Aliment Pharmacol Ther; 1997 Jun; 11(3):541-6. PubMed ID: 9218080
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
10. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of increasing doses of ranitidine for treatment of heartburn.
Pappa KA; Buaron K; Payne JE; Sirgo MA; Giefer EE
Aliment Pharmacol Ther; 1999 Apr; 13(4):475-81. PubMed ID: 10215731
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
Maton PN; Orlando R; Joelsson B
Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
[TBL] [Abstract][Full Text] [Related]
15. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
16. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
18. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
Hotz J; Plein K; Bunke R
Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599
[TBL] [Abstract][Full Text] [Related]
19. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
20. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
Jansen JB; Van Oene JC
Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
